Evidence map›Paper›PMID 24783013›Full record

ArticleEuropean thyroid journal2012

2012 European thyroid association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations.

R Paschke, M Niedziela, B Vaidya, L Persani, B Rapoport, J Leclere

Open access · bronzeAbstract read
In one paragraph

Article in European thyroid journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. ATranslational pediatrics · 2025
    Article
  3. Article
  4. Article
  5. A Novel TSHR Gene Mutation in a Family with Non-autoimmune Hyperthyroidism.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2024
    Article
  6. Review
  7. Article
  8. Screening, diagnosis and management of hyperthyroidism in pregnancy.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2022
    Article
  9. The Mysterious Universe of the TSH Receptor.Frontiers in endocrinology · 2022
    Review
  10. Review
  11. Hyperthyroidism in adolescents.Endocrine connections · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Hyperplasia in glands with hormone excess.Endocrine-related cancer · 2016
    Review
  19. Database(d) Guidelines: A Small World.European thyroid journal · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 5 countries.

R PaschkeDepartment of Endocrinology and Nephrology, Leipzig University, Leipzig, Germany.
M NiedzielaDepartment of Pediatric Endocrinology and Rheumatology, Poznan University of Medical Sciences, Poznan, Poland.
B VaidyaDepartment of Endocrinology, Royal Devon and Exeter Hospital, Peninsula Medical School, Exeter, UK.
L PersaniDepartment of Clinical Sciences, and Community Health, University of Milan, and Istituto Auxologico Italiano, Milan, Italy.
B RapoportAutoimmune Disease Unit, Cedars-Sinai Research Institute and School of Medicine, University of California, Los Angeles, Calif., USA.
J LeclereCentre Hospitalier Universitaire de Nancy, Nancy, France.
Centre Hospitalier Régional et Universitaire de Nancy · FRLeipzig University · DEPoznan University of Medical Sciences · PLRoyal Devon and Exeter Hospital · GBUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

All cases of familial thyrotoxicosis with absence of evidence of autoimmunity and all children with persistent isolated neonatal hyperthyroidism should be evaluated for familial non-autoimmune autosomal dominant hyperthyroidism (FNAH) or persistent sporadic non-autoimmune hyperthyroidism (PSNAH). First, all index patients should be analysed for the presence/absence of a thyroid-stimulating hormone (TSH) receptor (TSHR) germline mutation, and if they display a TSHR germline mutation, all other family members including asymptomatic and euthyroid family members should also be analysed. A functional characterization of all new TSHR mutations is necessary. Appropriate ablative therapy is recommended to avoid relapses of hyperthyroidism and its consequences, especially in children. Therefore, in children the diagnosis of FNAH or PSNAH needs to be established as early as possible in the presence of the clinical hallmarks of the disease.

Indexed as

Germline mutationsGuidelinesNon-autoimmune hyperthyroidismTSHR

Identifiers

PMID24783013
PMCPMC3821481
OpenAlexW2086540454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.